-
Product Insights
NewMevion Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Mevion Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Mevion Medical Systems Inc (Mevion), formerly Still River Systems is a medical equipment company that offers therapy systems. The company provides radiation therapy and proton therapy systems for the treatment of cancer. It provides MEVION S250 proton therapy system designed for preserving treatment benefits of traditional proton therapy systems. Mevion provides MEVION S250mx for scalable proton therapy solution...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naronapride in Corrosive Esophagitis (Erosive Esophagitis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naronapride in Corrosive Esophagitis (Erosive Esophagitis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Naronapride in Corrosive Esophagitis (Erosive Esophagitis) Drug Details: Naronapride...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD) Drug...
-
Product Insights
Likelihood of Approval Analysis for Peptic Ulcers
Overview How likely is it that the drugs in Peptic Ulcers will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peptic Ulcers Overview Peptic ulcers are open sores that develop on the...
-
Product Insights
NewVarian Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Varian Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Varian Medical Systems Inc (VMS) designs, manufactures, and sells medical devices, associated hardware and software, and a broad portfolio of interventional solutions for the treatment of cancer. The company’s major product areas include radiosurgery, radiotherapy, proton therapy, brachytherapy, adaptive therapy, interventional therapy, and software. VMS markets its products to private and government institutions, university research and community hospitals,...
-
Product Insights
NewRaysearch Laboratories AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Raysearch Laboratories AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. RaySearch Laboratories AB (RaySearch) is a medical technology company that develops software solutions for radiation therapy of cancer. The company provides software products such as rayplan, raycare, and raystation. Its services include installation, support, training and training schedule. RaySearch’s products provide automated planning, adaptive therapy solutions, proton therapy solutions, visual simulations and other solutions for oncology treatment. The company...
-
Product Insights
Likelihood of Approval Analysis for Uveal Melanoma
Overview How likely is it that the drugs in Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveal Melanoma Overview Uveal melanoma, the most common intraocular tumor, is a...
-
Product Insights
Likelihood of Approval Analysis for Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Overview How likely is it that the drugs in Clostridioides difficile Infections (Clostridium difficile Associated Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Clostridioides difficile Infections (Clostridium difficile Associated Disease)...
-
Product Insights
Likelihood of Approval Analysis for Hypersecretory Conditions
Overview How likely is it that the drugs in Hypersecretory Conditions will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypersecretory Conditions Overview Hypersecretory Condition is a group of disorders characterized by...